CA 15-3: A prognostic marker in breast cancer

International Journal of Biological Markers

Volumn 15, Issue 4, 2000, Pages 330-333

  Duffy, M J ^a   Shering, S ^a   Sherry, F ^a   McDermott, E ^a   O'Higgins, N ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Breast cancer; CA 15 3; MUC1; Prognosis; Tumor markers

Indexed keywords

CA 15-3 ANTIGEN; TUMOR MARKER;

BLOOD LEVEL; BREAST CANCER; CANCER SURVIVAL; CELL ADHESION; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RECURRENT CANCER; TREATMENT OUTCOME;

EID: 0034520850     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080001500410     Document Type: Conference Paper

References (22)

1. Prognostic and predictive markers in cancer
2. Biochemical markers as prognostic indices in cancer
3. HER-2/neu (c-erbB2) gene and protein in breast cancer
4. Prognostic and predictive value of p53 and p21 in breast cancer
5. Proteases as prognostic markers in cancer
6. International germ cell consensus classification: A prognostic factor based staging system for metastatic germ cell cancers
7. The clinical value of tumour markers in the management of ovarian cancer
8. Cell membrane-associated mucins and their adhesion modulating properties
9. MUC1 and cancer
10. A mechanism for inhibition of E cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1
11. Delayed mammary tumor progression in MUC1 null mice
12. The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer
13. CA 15-3 and related mucins as circulating markers in breast cancer
14. Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma in situ of the breast
15. Preoperative CA 15-3 concentrations predict outcome in breast cancer
16. Potential use of tumour marker CA 15-3 in the staging and prognosis of patients with breast cancer
17. Impact of preoperative CA 15-3 levels in operable breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA)
18. Tumor markers CEA and CA 15-3 as prognostic factors in breast cancer, univariate and multivariate analysis
19. Pre-operative tumour marker levels in patients with breast cancer and their prognosis
20. CA 15-3, a circulating marker with strong prognostic value in breast cancer, new observation
21. Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease
22. Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease